Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ruijin Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Baylor College of Medicine
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Peking University Cancer Hospital & Institute
Memorial Sloan Kettering Cancer Center
Peking Union Medical College Hospital
International Extranodal Lymphoma Study Group (IELSG)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Ruijin Hospital
Sun Yat-sen University
University of Aarhus
The Affiliated Hospital of Xuzhou Medical University
Chinese PLA General Hospital
Keimyung University Dongsan Medical Center